BioWorld MedTech

April 15, 2014

Medtronic faces debilitating U.S. injunction on CoreValve sales

Edwards Lifesciences (Irvine, California) has won an important battle in a six-year patent war with Medtronic (Minneapolis) over Medtronic's CoreValve transcatheter aortic valve replacement (TAVR/TAVI) system. Read More

Financings Roundup: Sant Ventures boosts size of most recent fund to $139 million

Final data from PRECISE trial to bepublished in American Heart Journal

Washington Roundup: Importers beware; Health Canada report cites SOPs for distribution

International report: Chiyoda Technol to distribute Mevion's S250 in Japan

Agreements/contracts: SBG Technology Solutions awarded VA contract extension for VistA

Deals roundup: Chindex receives M&A cash bid from buyer consortium

HIT Roundup: Osler to use Medworxx patient flow platform

Syneron gets clearance for UltraShape system

Product briefs

Briefly Noted

People in Places

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan. 13, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for January 13, 2025

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

BioWorld

The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...

Proteomics study explores how protein changes influence disease

BioWorld Science

Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

BioWorld

Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...